Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02718300
Title A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications

myelofibrosis

Therapies

Parsaclisib + Ruxolitinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.